OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0938-AQ41 View EO 12866 Meetings | Received Date: 08/04/2015 |
| Title: Covered Outpatient Drugs (CMS-2345-F) | |
| Agency/Subagency: HHS / CMS | Stage: Final Rule |
| Concluded Action: Consistent with Change | Concluded Date: 12/11/2015 |
| Legal Deadline: Statutory | Economically Significant: Yes |
| Publication Date: 02/01/2016 | Unfunded Mandates: No |
| Major: Yes | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: Yes | Small Entities Affected: Businesses |
| Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: Yes |
| International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
